Remove Bioethics Remove COVID-19 Remove COVID-19 Vaccine Remove Public Health
article thumbnail

Conclusion to the Symposium: From Principles to Practice: Human Rights and Public Health Emergencies

Bill of Health

While receiving significant global traction and acceptance since their publication in 1985, the Siracusa Principles, the authors argue, proved to be simply “unequal to the task” of guiding States’ conduct in the context of COVID-19 because they are “unable to speak in any significant detail to the particular concerns of public health crises.”

article thumbnail

How to Fairly Allocate Scarce COVID-19 Therapies

Bill of Health

Vaccines are no longer our only medical intervention for preventing severe COVID-19. Older and medically vulnerable people who continue to face high risk of COVID-19 illness after vaccination should not be asked to wait in line behind adults who refused vaccines.

COVID-19 209
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Introduction to the Symposium: From Principles to Practice: Human Rights and Public Health Emergencies

Bill of Health

By Roojin Habibi, Timothy Fish Hodgson, and Alicia Ely Yamin Today, as the world transitions from living in the grips of a novel coronavirus to living with an entrenched, widespread infectious disease known as COVID-19, global appreciation for the human rights implications of public health crises are once again rapidly fading from view.

article thumbnail

Depoliticizing Social Murder in the COVID-19 Pandemic

Bill of Health

I can say personally, my mother quit her job at a warehouse due to fear of COVID-19 exposure and took a lower paying job in a retail establishment with better infection mitigation measures.) The post Depoliticizing Social Murder in the COVID-19 Pandemic appeared first on Bill of Health.

COVID-19 364
article thumbnail

Reasonable Pricing Clauses: A First Step Toward Ensuring Taxpayers a Fair Return on their Public R&D Investment

Bill of Health

By Nikhil Chaudhry and Reshma Ramachandran Earlier this month, the Department of Health and Human Services announced that it had successfully included a reasonable pricing provision in a $326M investment contract with Regeneron for development of a next generation monoclonal antibody therapy for COVID-19. pharmaceutical market.

COVID-19 205
article thumbnail

Health Disparities and the Risks of Social Determinants for COVID-19 – 14 Months of Evidence

Health Populi

Within just a couple of months of COVID-19 emerging in America, it became clear that health disparities were evident in outcomes due to complications from the coronavirus. The rate of vaccinations against the coronavirus, too, significantly varied by race and ethnicity as of March 11, 2021. In the U.S., population).

COVID-19 162
article thumbnail

The Years of Magical Thinking: Pandemic Necrosecurity Under Trump and Biden

Bill of Health

No other country has recorded as many total COVID-19 casualties as the United States — indeed, no other country comes close. From early moments in 2020, the concept of a right to health — and indeed, even a right to life — has been discounted in American policy, discourse, and practice. This situation is not happenstance.

COVID-19 356